Benjamin Cravatt's most recent trade in FibroGen Inc was a trade of 70,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| FibroGen Inc | Benjamin F. Cravatt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Benjamin Cravatt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 12,666 | 12,666 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Benjamin Cravatt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 8,289 | 32,680 (0%) | 0% | 0 | Common Stock | |
| FibroGen Inc | Benjamin Cravatt | Director | Sale of securities on an exchange or to another person at price $ 17.51 per share. | 07 Jun 2023 | 2,178 | 28,736 (0%) | 0% | 17.5 | 38,137 | Common Stock |
| FibroGen Inc | Benjamin Cravatt | Director | Sale of securities on an exchange or to another person at price $ 16.75 per share. | 07 Jun 2023 | 1,766 | 30,914 (0%) | 0% | 16.8 | 29,581 | Common Stock |
| FibroGen Inc | Benjamin Cravatt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 25,684 | 25,684 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Benjamin Cravatt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 15,777 | 24,391 (0%) | 0% | 0 | Common Stock | |
| FibroGen Inc | Benjamin Cravatt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 7,800 | 7,800 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Benjamin Cravatt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 4,700 | 8,614 (0%) | 0% | 0 | Common Stock | |
| FibroGen Inc | Benjamin Cravatt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 10,400 | 10,400 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Benjamin Cravatt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 6,496 | 6,496 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Benjamin Cravatt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 3,914 | 3,914 (0%) | 0% | 0 | Common Stock |